Bartlit Beck LLP

Chairman: Sidney Herman

Managing Partner: Jason Peltz

Number of lawyers: 86

Firm Overview: 

In 1993, the founders of Bartlit Beck left Kirkland & Ellis to start a new type of firm — one free from the billable hour. This billing model aligned the client’s and the firm’s interests with a singular focus on achieving extraordinary outcomes. The expertise of Bartlit Beck’s litigation practice is trying and winning high-stakes cases, and the firm’s corporate attorneys represent clients in a wide variety of complex transactions, focusing on middle-market mergers and acquisitions.

Main Areas of Practice:  

Trial Practice: 

Bartlit Beck’s trial practice model is different. Because experience is needed to win complex, high-stakes cases, over 80% of the firm’s lawyers are partners, resulting in the average lawyer having 17 years of experience. Eighty percent of the firm’s lawyers have argued substantive motions that went to trial in 2019. One-half of Bartlit Beck litigators have first-chair commercial civil trial experience gained at the firm. This model has enabled Bartlit Beck to attract industry-leading talent. Fifteen percent of the firm’s trial lawyers are former U.S. Supreme Court clerks.

The firm’s litigation clients include Bayer, Johnson & Johnson, Gilead, ConocoPhillips, Sabre Spirit AeroSystems, UnitedHealth Group and USG.

Contact: Sara Anstoetter

Tel: 312-494-4130

Email: [email protected]

Corporate Practice: 

Bartlit Beck’s corporate practice emphasizes quality, responsiveness and efficiency by utilizing small deal teams with actively involved senior partners on each transaction. Employing this unique model, Bartlit Beck has established itself as a premier provider of high-quality transactional legal services to private equity funds focused in the middle market, other investment funds, and companies operating in a range of industries. The firm’s corporate lawyers have extensive experience in a wide variety of transactions, including mergers and acquisitions, securities offerings and compliance issues, corporate finance, private equity and hedge fund formation, and counseling on sensitive corporate governance matters.

Contact: Rob Morrill

Tel: 303-592-3126

Email: [email protected]